OPPM

Opus Point Partners Management Portfolio holdings

AUM $46.9M
1-Year Est. Return 4.17%
This Quarter Est. Return
1 Year Est. Return
-4.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$46.9M
AUM Growth
-$11.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
64
New
Increased
Reduced
Closed

Top Buys

1
+$535K
2
+$279K
3
+$258K
4
ALKS icon
Alkermes
ALKS
+$227K
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$60.5K

Top Sells

1
+$868K
2
+$813K
3
+$743K
4
INSM icon
Insmed
INSM
+$690K
5
PCRX icon
Pacira BioSciences
PCRX
+$489K

Sector Composition

1 Healthcare 64.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BPMC
26
DELISTED
Blueprint Medicines
BPMC
$498K 0.9%
6,780
BOLD
27
DELISTED
Audentes Therapeutics, Inc
BOLD
$487K 0.88%
17,339
GTHX
28
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$475K 0.86%
20,844
GBT
29
DELISTED
Global Blood Therapeutics, Inc.
GBT
$460K 0.83%
9,479
BHVN
30
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$453K 0.82%
10,852
ARNA
31
DELISTED
Arena Pharmaceuticals Inc
ARNA
$447K 0.81%
9,770
ACAD icon
32
Acadia Pharmaceuticals
ACAD
$4.3B
$432K 0.78%
12,005
+24
GWPH
33
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$423K 0.76%
3,674
ZGNX
34
DELISTED
Zogenix, Inc.
ZGNX
$389K 0.7%
9,725
MGNX icon
35
MacroGenics
MGNX
$89.8M
$384K 0.69%
30,075
NTLA icon
36
Intellia Therapeutics
NTLA
$938M
$380K 0.69%
28,490
TECH icon
37
Bio-Techne
TECH
$9.81B
$303K 0.55%
6,204
IQV icon
38
IQVIA
IQV
$38.4B
$297K 0.54%
1,985
AMGN icon
39
Amgen
AMGN
$182B
$294K 0.53%
1,518
+121
NBIX icon
40
Neurocrine Biosciences
NBIX
$15.2B
$282K 0.51%
3,127
+115
CKPT
41
DELISTED
Checkpoint Therapeutics
CKPT
$281K 0.51%
11,276
CRL icon
42
Charles River Laboratories
CRL
$8.6B
$280K 0.51%
2,112
UTHR icon
43
United Therapeutics
UTHR
$20.4B
$279K 0.5%
+3,498
GRFS icon
44
Grifois
GRFS
$5.79B
$264K 0.48%
13,196
BIIB icon
45
Biogen
BIIB
$26.4B
$261K 0.47%
1,123
ICPT
46
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$261K 0.47%
3,926
-1,946
GILD icon
47
Gilead Sciences
GILD
$154B
$259K 0.47%
4,082
LGND icon
48
Ligand Pharmaceuticals
LGND
$3.84B
$242K 0.44%
3,892
+508
NKTR icon
49
Nektar Therapeutics
NKTR
$1.12B
$235K 0.42%
862
+28
EXEL icon
50
Exelixis
EXEL
$11.6B
$232K 0.42%
13,132
+1,692
1
2
3